Cantabio in the News

Chaperoning the DJ

Chaperoning the DJ

Cover Story by Biocentury Innovations, describing how Cantabio is using an alternative approach, enhancing the function of the DJ-1 protein, rather than the more common dopamine compensation strategy. This means developing a disease-modifying therapy instead of treating only the disease's symptoms. Mentioning also our pharmacological chaperone approach in Alzheimer's targeting B-amyloid and tau.